Back to Agenda
Session 3, Track A: Reducing Burden, Accelerating Access - How Health Canada Is Streamlining Regulatory Work
Session Chair(s)
Myriam Salem
National Supervisor, Regulatory Operations and Enforcement Branch, Health Canada, Canada
Yatika Kohli, MBA
Chief Compliance and Strategy Officer, NoNO Inc, Canada
This session highlights Health Canada’s ongoing efforts to reduce regulatory burden, strengthen collaboration, and accelerate access to innovative therapies. Through three focused presentations, Health Canada will outline its latest red tape reduction initiatives designed to streamline processes and improve regulatory efficiency; provide an update on data sharing initiative that supports smarter, more connected regulatory decision making; and share insights on oncology drug approvals under the NOC/c pathway, including how evidence generation, international reliance, and regulatory agility are being leveraged to bring promising cancer therapies to patients sooner. Together, these presentations offer a comprehensive view of how Health Canada is modernizing its regulatory approach to deliver faster, more predictable, and more efficient outcomes for patients and industry.
Speaker(s)
Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis
Jan Brun, PhD
Senior Clinical Oncology Reviewer, Health Canada, Canada
Speaker
Representative Invited
Executive Director, Regulatory Enablement Services (RES), Health Canada, Canada
Speaker
Representative Invited
Director, Bureau of Cardiology, Allergy and Neurological Science, Health Canada, Canada
Have an account?